• 1
    Namen A E, Schmierer A, March C J, Overell R W, Park L S, Urdal D L, Mochizuki D Y. B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med 1988: 167: 9881002.
  • 2
    Murray R, Suda T, Wrighton N, Lee F, Zlotnik A. IL-7 is a growth and maintenance factor formature and immature thymocyte subsets. Int Immunol 1989: 1: 526531.
  • 3
    Sakata T, Iwagami S, Tsuruta Y, Teraoka H, Tatsumi Y, Kita Y, Nishikawa S I, Takai Y, Fujiwara H. Constitutive expression in interleukin-7 mRNA and production of IL-7 by a cloned murine thymic stromal cell line. J Leukocyte Biol 1990: 48: 205212.
  • 4
    Wolf SS, Cohen A. Expression of cytokines and their receptors by human thymocytes and thymic stromal cells. Immunology 1992: 77: 362368.
  • 5
    Dalloul A, Laroche L, Bagot M, Mossalayi M D, Fourcade C, Thacker D J, Hogge D E, Merie-Beral H, Debre P, Schmitt C Interleukin-7 is a growth factor for Sezary lymphoma cells. J Clin Invest 1992: 90: 10541060.
  • 6
    Heufler C, Topar G, Grasseger A, Stanzl U, Koch F, Romani N, Namen A E, Schuler G. Interleukin 7 is produced by murine and human keratinocytes. J Exp Med 1993: 178: 11091114.
  • 7
    Hickman C J, Crim J A, Mostowski H S, Siegel J P. Regulation of human cytotoxic T lymphocyte development by IL- 7. J Immunol. 1990: 145: 24152420.
  • 8
    Alderson M R, Tough T W, Ziegler S F, Grabstein K H. Interlcukin-7 induces cytokine secretion and tumoricidal activity by human peripheral monocytes. J Exp Med 1991: 173: 923930.
  • 9
    Kirnbauer R, Charvat B, Schauer E, Köck A, Urbanski A, Förster E, Neuner P, Assmann I, Luger T, Schwarz T. Modulation of intercellular adhesion molecule-1 expression on human melanocytes and melanoma cells: evidence for a regulatory role of IL-6. Il-7. TNF-β, and UVB light. J Invest Dermatol 1992: 98: 320326.
  • 10
    LugerT A, SchwarzT, ed. Epidermal growth factors and cytokines. New York , Basel , Hong Kong : Marcel Dekker, Inc. 1994.
  • 11
    Salmon J K, Armstrong C A, Ansel J C. The skin as an immune organ. West J Med 1994: 160: 146151.
  • 12
    Goodwin R G, Lupton S, Schmierer A, Hjerrild K J, Jerzy R, Clevenger W, Gilis S, Cosman D, Namen A E. Human interleukin-7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA 1989: 86: 302306.
  • 13
    Sutherland G R, Baker E, Fernanez K E, et al. The gene of human interleukin 7 (IL-7) is at 8q12–13. Human Genet 1989: 82: 371372.
  • 14
    Foxwell B M, Taylor-Fishwick D A, Simon J L, Page T H, Londei M. Activation induced changes in expression and structure of the IL-7 receptor on human T cells. Int. Immunol 1992: 4: 277282.
  • 15
    Armitage R J, Ziegler S F, Friend D J, Park L S, Fanslow W C. Identification of a novel low-affinity receptor for human interleukin-7. Blood 1992: 7: 17381745.
  • 16
    Park L S, Friend D J, Schmierer A E, et al. Murine interleukin-7 (IL-7) receptor. Characterization on an IL-7-dependent cell line. J Exp Med 1990: 171: 10731089.
  • 17
    Goodwin R G, Friend D, Ziegler S F, Jerzy R, Falk B A, Gimpel S, Cosman D, Dower S K, March C J, Namen A E, Park L S. Cloning of human and murine interleukin-7 receptor: demonstration of a soluble form and homology to a new receptor superfamily. Cell 1990: 60: 941951.
  • 18
    Page T H, Willcocks J L, Taylor-Fishwick D A, Fozwell B M J. Characterization of a novel high affinity human IL-7 receptor. J Immunol 1993: 151: 47534763.
  • 19
    Foxwell B M J, Willcocks J L, Taylor-Fishwick, Kulig K, Ryffel B, Londei M. Inhibition of activation-induced changes in the structure of the T cell interleukin-7 receptor by cyclosporin A and FK506. Eur J Immunol 1993: 23: 8389.
  • 20
    Noguchi M, Nukamura Y, Russell S M, Ziegler S F, Tsang M, Cao X, Leonard W J. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 1993: 262: 18771880.
  • 21
    Cosman D, Lyman S D, Idzerda R L. A new cytokine receptor family. TIBS 1990: 15: 265270.
  • 22
    Dadi H K, Ke S, Roifman C M. Interleukin-7 receptor mediates the activation of phosphatidylinositol-3 kinase in human B-cell precursors. Biochem Biophys Res Commun 1993: 192: 459464.
  • 23
    Touw I, Powels K, Van-Agthoven T, Van-Gurp R, Budel L, Hoogerbrugge H, Delwel R, Goodwin R, Namen A, Lowenberg B. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood 1990: 75: 20972101.
  • 24
    Seckinger P, Milili M, Schiff C, Fougereau M. Interleukin-7 regulates c-myc expression in murine T cells and thymocytes: a role for tyrosinase(s) and calcium mobilization. Eur J Immunol 1994: 24: 716722.
  • 25
    Yip-Schneider M T, Horie M, Broxmeyer H E. Characterization of interleukin-7-induced changes in tyrosine phosphorylation and c-myc gene expression in normal human T cells. Expr Hematol 1993: 21: 16481656.
  • 26
    Dibirdik I, Langlie M C, Ledbetter J A. Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation. phosphoinositide turnover and clonal proliferation of human T lineage acute lymphoblastic leukemia cells. Blood 1991: 78: 564570.
  • 27
    Anderson D, Bisaccia E, Klainer A, Böhm M, Edelson R, Halaban R, Berger C. IL-7 signal transduction in CTCL. J Invest Dermatol 1994: 102: 588a.
  • 28
    Venkirtaraman A R, Cowling R J. Interleukin-7 receptor functions by recruiting the tyrosiune kinase p59fyn through a segment of its cytoplasmatic tail. Proc Nail Acad Sci USA 1992: 89: 1208312087.
  • 29
    Uckun F M, Tuel-Ahlgren I, Obuz V, Smith R, Dibirdik I, Hanson M, Langlie M-C, Ledbetter J A. Interleukin-7 receptor engagement stimulates tyrosine phosphorylation. inositol phospholipid turnover, proliferation, and selective differentiation to the CD4 lineage by human fetal thymocytes. Proc Natl Acad Sci USA 1991: 88: 63236327.
  • 30
    Roifman C M, Wang G, Freedman M, Pan Z. IL-7 receptor mediates tyrosine phosphorylation but does not activate the phosphatidylinositol-pliospholipase C-gamma l pathway. J Immunol 1992: 148: 11361142.
  • 31
    Londei M, Verhoef A, Hawrylowicz C, Groves J, De Berardinis P, Feldmann M. Interleukin-7 is a growth factor for mature human T cells. Eur J Immunol 1990: 20: 425428.
  • 32
    Armitage R J, Namen A E, Sassenfeld H M, Grabstein K H. Regulation of human T cell proliferation by IL-7. J Immunol 1990: 144: 938941.
  • 33
    Costello R, Braily H, Mallet F, Mawas C, Olive D. Interleukin-7, in association with CD2 and CD28 adhesion molecules stimulation, is a potent costimulus of T-cell proliferation and cytokine secretion. Immunology 1993: 80: 451457.
  • 34
    Chazen G D, Pereira G M, LeGros G, Gillis S, Shevach E M. Interleukin-7 is a T-cell growth factor. Proc Nail Acad Sci USA 1989: 86: 59235927.
  • 35
    Watson J D, Morrissey P J, Namen A E, et al. Effect of IL-7 on the growth of fetal thymocytes in culture. J Immunol. 1989: 143: 12151222.
  • 36
    Tsukuda M, Mochimatsu I, Sakumoto M, Mikami Y, Yuyama S, Yanoma S. The synergistic effects of interleukin-2 and interleukin-7 on the proliferation and autologous tumor cell lysis of tumor cell lysis of tumor-associated lymphocytes. Biotherapy 1993: 6: 167174.
  • 37
    Lynch D H, Miller R E. Induction of murine lymphokine- activated killer cells by recombinant IL-7. J Immunol 1990: 145: 19831990.
  • 38
    Alderson M R, Sassenfeld H M, Widmer M B. Interleukin-7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood. J Exp Med 1990: 172: 577587.
  • 39
    Naume B, Espevik T. Effects of IL-7 and IL-2 on highly enriched CD56 + natural killer cells. J Immunol 1991: 147: 22082214.
  • 40
    Smyth M J, Norihisa Y, Gerard J, Young H A, Ortaldo J R. IL-7 regulation of cytotoxic lymphocytes: pore-forming protein gene expression, interferon-gamma production, and cytotoxicity of human peripheral blood lymphocyte sub-sets. Cell Immunol 1991: 138: 390403.
  • 41
    Schadendorf D, Böhm M, Möller P, Grünewald T, Czarnetzki B M. Interleukin-7 induces differential lymphokine- activated killer cell activity against human melanoma cells, keratinocytes, and endothelial cells. J Invest Dermatol 1994: 106: 838842.
  • 42
    Böhm M. Möller P. Kalbfleisch U. Worm M. Czarnetzki B M. Schadendorf D. Lysis of allogenic and autologous melanoma cells by lL-7-induced lymphokine-activated killer cells. Br J Cancer 1994: 70: 5459.
  • 43
    Joshi P C, Choi Y S. Human interleukin-7 is a B cell growth factor for activated B cells. Eur J Immunol 1991: 21: 681686.
  • 44
    Suda, T, Zlotnik A. IL-7 maintains the T cell precursor potential of CD3-CD4-CD8-thymocytes. J Immunol 1991: 146: 30683073.
  • 45
    Appasamy P M. lnterleukin-7-induced TCR gamma gene expression by pre-T cells in murine fetal liver cells in murine fetal liver cultures. J Immunol 1992: 149: 16491656.
  • 46
    Muegge K, Vila M P, Durum S K. Interleukin-7: a cofactor for V(D)J erarrangement of the T-cell receptor β gene. Science 1993: 261: 9395.
  • 47
    Grabstein K H, Waldsehmidt T J, Finkelman F D, Hess B W, Alpert A R, Boiani N E, Namen A E, Morrissey P J. Inhibition of murine B and T lymphopoiesis in vivo by an anti-inierleukin-7 monoclonal antibody. J Exp Med 1993 178: 257264.
  • 48
    Fisher A G, Burdet C, LeMeur M, Haasner D, Gerber P, Ceredig R. Lymphoproliferative disorders in an IL-7 transgenic mouse line. Leukemia 1993: 7: S6668.
  • 49
    Rich B J, Campos-Torres J, Tepper R, Moreadith R W, Leder P. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J Exp Med 1993: 177: 305316.
  • 50
    Samaradis J, Casorati G, Traunecker A, et al. Development of lymphocytes in interluekin 7-transgenic mice. Eur J Immunol 1991: 21: 435460.
  • 51
    Uehira M, Matsuda H, Hikita I, Sakata T, Fujiwara H, Nishimoto H. The development of dermatitis infiltrated by gamma delta T cells in IL-7 transgenic mice. Int Immunol 1993: 5: 16191627.
  • 52
    Morrissey P J, Conlon P, Charrier K, et al. Administration of IL-7 10 normal mice stimulates B lymphopoiesis and peripheral lymphadenopathy. J Immunol 1991: 147: 561568.
  • 53
    Morrissey P J, Conlon P J, Braddy S, Williams D E, Namen A E, Mochizuki D Y. Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation. J Immunol 1991: 46: 15471552.
  • 54
    Damia G, Komschlies K L, Faltynek C R, Ruscetti F W, Wiltrout R H. Administration of recombinant human interleukin-7 alters the frequency and number of myeloid progenitor cells in the bone marrow and spleen of mice. Blood 1992: 79: 11211129.
  • 55
    Ziegler S F, Tough T W, Franklin T L, Armitage R J, Alderson M R. Induction of macrophage inflammatory protein-1 beta gene expression in human monocytes by lipopolysaceharides and IL-7. J Immunol. 1991: 147: 22342239.
  • 56
    Makrynikola V, Kabral A, Bradstock K. Effects of interleukin-7 on the growth of clonogenic cells in the T-cell acute lymphoblastic leukaemia. Leuk Res 1991: 15: 879882.
  • 57
    Masuda M, Takanashi M, Motoji T, Oshimi K, Mizoguchi H. Effects of interleukins 1–7 on the proliferation of T-linage acute lymphoblastic leukemia cells. Leuk Res 1991: 15: 10911096.
  • 58
    Yoshioka R, Shimizu S, Tachibana J, Hirose Y, Fukutoku M, Takeuchi Y, Sugai S, Takiguchi T, Konda S. Interleukin-7 (IL-7)-induced proliferation of CD8+T-chronic lymphocytic leukemia cells. J Clin Immunol 1992: 12: 101106.
  • 59
    Digel W, Schmid M, Heil G, Conrad P, Gillis S, Porzsolt F. Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemia. Blood 1991: 87: 753759.
  • 60
    Eder M, Oltmann O G, Hansen-Hagge T E, Bartram C R, Falk S, Gillis S, Hoelzer D, Ganser A. In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3. interleukin-7, and accessory cells. Blood 1992: 79: 32743284.
  • 61
    Pandrau D, Frances V, Martinez-Valdez H, Pages M P, Manel A-M, Phillippe N, Banchereau J, Saeland S. Characterization of a 1(1:19) pre-B acute lymphoblastic leukemia (ALL) cell line which proliferates in response to IL-7. Leukemia 1993: 7: 635642.
  • 62
    Frishman J, Long B, Knospe W, Gregory S, Plate J. Genes for interleukin-7 are transcribed in leukemic cell subsets of individuals with chronic lymphocytic leukemia. J Exp Med 1993: 177: 955964.
  • 63
    Foss F M, Koc Y, Stetler-Stevenson M A, Mguyen D T, O'Brien M C, Turner R, Sausville E A. Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in Sezary syndrome. J Clin Oncol 1994: 12: 326335.
  • 64
    Abrams J T, Lessin S R, Ghosh S K, Nowell P C, Ju W, Vonderheid E C, Rook A H, DeFreitas E. Malignant and nonmalignant T cell lines from human lymphotropic virus type I-negative patients with Sezary syndrome. J Immunol 1991: 146: 14551462.
  • 65
    Poiesz B J, Ruscetti F W, Mier J W, Moods A M, Gallo R C. T-cell lines established from T-lymphocytic neoplasia by direct response to T-cell growth factor. Proc Natl Acad Sci USA 1980: 70: 68156819.
  • 66
    Rosenberg S A, Lotze M T, Muul L M, Leitman S, Chang A E, Ettinghausen S E, Matory Y L J M, Shilow E, Vetto J F. Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with cancer. N Engl. J Med 1985: 313: 14851492.
  • 67
    Rosenberg S A, Lotze M T, Muul L M, Chang A E, Avis F P, Leitman S, Linehan W M, Robertson C N, Lee R E, Rubin J T. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. New Engl. J Med 1987: 316: 889897.
  • 68
    Lynch D H, Namen A E, Miller R E. In vivo evaluation of the effects of interleukin 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes. Eur J Immunol 1991: 21: 29772985.
  • 69
    Jicha D L, Mule J J, Rosenberg S A. Interleukin-7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy. J Exp Med 1991: 174: 15111515.
  • 70
    Murphy W J, Back T C, Conlon K C, Komschlies K L, Ortaldo J R. Antitumor Effects of Interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts. J Clin Invest 1993: 92: 19181924.
  • 71
    McBride W H, Thacker J C, Comora S, Economou J S. Kelly D. Hogge D, Dubinett S M, Dougherty G J. Genetic modification of a murine fibrosarcoma to produce interleukin-7 stimulates host cell infiltration and tumor immunity. Cancer Res 1992: 52: 39313937.
  • 72
    Lotze M T, Zeh H J, Elder E M, Cai Q, Pippin B A, Rosenstein M M, Whiteside T L, Herberman R. Use of T-cell growth factors (interleukin-2, 4, 7. 10 and 12) in the evaluation of T-cell reactivity to melanoma. J Immunother 1992: 12: 212217.
  • 73
    Sica D, Rayman P, Stanley J, Edinger M, Tubbis R R, Klein E, Bukowski R, Finke J H. Interleukin-7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma. Int J Cancer 1993: 53: 941947.
  • 74
    Lynch D H, Miller R E. Interleukin-7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J Exp Med 1993: 179: 3142.
  • 75
    Cohen P A, Kim H, Fowler D H, Gress R E, Jakobsen M K, Alexander R B, Mule J J, Carter C, Rosengerg S A. Use of Interleukin-7, interleukin-2, and Interferon-gamma to propagate CD4+T cells in culture with maintained antigen specifity. J Immunother 1993: 14: 242252.
  • 76
    Colombo M P, Forni G. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol Today 1994: 15: 4851.
  • 77
    Aoki T, Tashiro K, Miyatake S-I, Kinashi T, Nakano T, Oda Y, Kikuchi H, Honjo T. Expression of murine interleukin-7 in a murine glioma cell line results in reduced tumor- igenicity in vivo. Proc Natl Acad Sci USA 1992: 89: 38503854.
  • 78
    Hock H, Dorsch M, Diamantstein T, Blankenstein T. Interleukin/induces CD4 + T cell-dependent tumor rejection. J Med Exp 1991: 174: 12921298.
  • 79
    Hock H, Dorsch M, Kunszendorf U, Überla K, Zhihai Q, Diamantstein T, Blankenstein T. Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to classical adjuvant. Cancer Res 1993: 53: 714716.
  • 80
    Hock H, Dorsch M, Kunzendorf U, Zhihai Q, Diamantstein T, Blankenstein T. Mechanisms of rejection induced by tumor cell-targeted gene transfer of Interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci USA 1993: 90: 27742778.
  • 81
    Miller A R, McBride W H, Dubinelt, Dougherty G J, Thacker J D, Shau H, Kohn D BMoen R C, Walker M J, Chiu R, Schuck B LRosenblatt J A, Huang M, Dhanani S, Rhoades K, Economou J. Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gen transfer: comparison of immunologic properties with interleukin-2. Blood 1993: 82: 36863694.
  • 82
    Stöttter H, Custer M C, Bolton E S, Guedez LLotze M T. IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4. J Immunol 1991: 146: 150155.
  • 83
    Dang L H, Michalek M T, Takei F Benaceraff B, Rock K L. Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutants. J Immunol 1990: 144: 40824091.
  • 84
    Johnson J P, Stade B G, Holzmann B, Schwäble W, Riethmüller B G. De novo expression of intercellular-adhesion molecule-1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 1989: 86: 641644.
  • 85
    Mattei S, Colombo M P Melani C, Silvani A, Parmiani G, Herlyn M. Expression of cytokines/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994: 56: 853857.
  • 86
    Matsue H. Bergstresser P R. Takashima A. Keratinocyte- derived IL-7 serves as a growth factor for dentritic epidermal T cell in mice. J Immunol 1993: 151: 60126019.
  • 87
    Sakimura L, Yamamura M, Sieling P A, Nickoloff B, Rea T H, Modlin R L. Expression of interleukin-7 mRNA in human skin. J Invest Dermatol 1993: 100: 561a.
  • 88
    Matsue H, Bergstresser P R, Takashima A. Reciprocal cytokine-mediated cellular interactions in mouse epidermis: promotion of gamma-delta T-cell growth by IL-7 and TNF- alpha and inhibition of keratinocyte growth by IFN- gamma. J Invest Dermatol 1993: 101: 543548.
  • 89
    Miyauchi S, Hashimoto K. Thy-1 +dentritic epidermal cells undergo mitosis in vivo. J Invest Dermatol 1989: 93: 429431.
  • 90
    Bunn P A, Edelson R, Ford S S, Shackney S and E. Patterns of cell proliferation and cell migration in the Sezary syndrome. Blood 1981: 57: 452463.
  • 91
    Schwarmeier J D, Paietta E, Radaskiewicz T, Konrad K, Marosi L. Proliferation kinetics of Sezary cells. Blood 1981: 57: 10491054.